The reason why LM being a strong TLR2 agonist in the HEK293 assay, does not co-stimulate or significantly increase HIV-1 infection in primary CD4+ T cells may be related to a dominant TCR inhibitory effect of this glycolipid. The gene discussed is CD4; the disease is HIV-1 infection.